Sivenius J - Search Results

1

European Stroke Prevention Study. 2. Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke.

Diener HC, Cunha L, Forbes C, Sivenius J, Smets P, Lowenthal A. Diener HC, et al. Among authors: sivenius j. J Neurol Sci. 1996 Nov;143(1-2):1-13. doi: 10.1016/s0022-510x(96)00308-5. J Neurol Sci. 1996. PMID: 8981292 Clinical Trial.

2

Dipyridamole for preventing recurrent ischemic stroke and other vascular events: a meta-analysis of individual patient data from randomized controlled trials.

Leonardi-Bee J, Bath PM, Bousser MG, Davalos A, Diener HC, Guiraud-Chaumeil B, Sivenius J, Yatsu F, Dewey ME; Dipyridamole in Stroke Collaboration (DISC). Leonardi-Bee J, et al. Among authors: sivenius j. Stroke. 2005 Jan;36(1):162-8. doi: 10.1161/01.STR.0000149621.95215.ea. Epub 2004 Nov 29. Stroke. 2005. PMID: 15569877 Review.

3

Efficacy of aspirin plus extended-release dipyridamole in preventing recurrent stroke in high-risk populations.

Sacco RL, Sivenius J, Diener HC. Sacco RL, et al. Among authors: sivenius j. Arch Neurol. 2005 Mar;62(3):403-8. doi: 10.1001/archneur.62.3.403. Arch Neurol. 2005. PMID: 15767505

4

Antiplatelet treatment does not reduce the severity of subsequent stroke. European Stroke Prevention Study 2 Working Group.

Sivenius J, Cunha L, Diener HC, Forbes C, Laakso M, Lowenthal A, Smets P, Riekkinen P Sr. Sivenius J, et al. Neurology. 1999 Sep 11;53(4):825-9. doi: 10.1212/wnl.53.4.825. Neurology. 1999. PMID: 10489049 Clinical Trial.

5

The role of dipyridamole in stroke prevention.

Sivenius J, Diener HC. Sivenius J, et al. Eur Neurol. 1996;36(5):253-6. doi: 10.1159/000117268. Eur Neurol. 1996. PMID: 8864702 Review. No abstract available.

6

Antiplatelet therapy is effective in primary prevention of myocardial infarction in patients with a previous cerebrovascular ischemic event.

Sivenius J, Riekkinen PJ, Lowenthal A, Smets P, Laakso M. Sivenius J, et al. Arch Neurol. 1993 Jul;50(7):710-3. doi: 10.1001/archneur.1993.00540070030010. Arch Neurol. 1993. PMID: 8323473 Clinical Trial.

7

European stroke prevention study: effectiveness of antiplatelet therapy in diabetic patients in secondary prevention of stroke.

Sivenius J, Laakso M, Riekkinen P Sr, Smets P, Lowenthal A. Sivenius J, et al. Stroke. 1992 Jun;23(6):851-4. doi: 10.1161/01.str.23.6.851. Stroke. 1992. PMID: 1595104 Clinical Trial.

8

European Stroke Prevention Study 2: Baseline data.

Bertrand-Hardy JM, Cunha L, Forbes C, Hoeven C, Hogenhuis L, Lowenthal A, Pathy J, Sivenius J, Smets P, Welbers I, et al. Bertrand-Hardy JM, et al. Among authors: sivenius j. J Neurol Sci. 1995 Aug;131 Suppl:1-58. J Neurol Sci. 1995. PMID: 7500119 Clinical Trial. No abstract available.

9

European Stroke Prevention Study (ESPS): antithrombotic therapy is also effective in the elderly.

Sivenius J, Riekkinen PJ, Laakso M, Smets P, Lowenthal A. Sivenius J, et al. Acta Neurol Scand. 1993 Feb;87(2):111-4. doi: 10.1111/j.1600-0404.1993.tb04087.x. Acta Neurol Scand. 1993. PMID: 8442393 Clinical Trial.

10

Second European Stroke Prevention Study: antiplatelet therapy is effective regardless of age. ESPS2 Working Group.

Sivenius J, Cunha L, Diener HC, Forbes C, Laakso M, Lowenthal A, Smets P, Riekkinen P Sr. Sivenius J, et al. Acta Neurol Scand. 1999 Jan;99(1):54-60. doi: 10.1111/j.1600-0404.1999.tb00658.x. Acta Neurol Scand. 1999. PMID: 9925239 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results